<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
--------
OSIRIS THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 34-1728301
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
--------
2001 Aliceanna Street
Baltimore, Maryland 21231
(Address of principal executive offices) (zip code)
<TABLE>
<S> <C>
If this form relates to the registration of If this form relates to the registration of a
a class of securities pursuant to Section class of securities pursuant to Section 12(g)
12(b) of the Exchange Act and is effective of the Exchange Ac and is effective pursuant
pursuant to General Instruction A.(c), to General Instruction A.(d), check the
check the following box. / / following box. /X/
</TABLE>
Securities Act registration statement
file number to which this form relates:
333-31435
----------------------------------------
(if applicable)
Securities to be registered pursuant to Section 12(b) of the Act: None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.001 per share
(Title of Class)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED
Information with respect to the Common Stock, par value $.001 per share
(the "Common Stock"), of the Registrant is incorporated by reference to the
sections captioned "Description of Capital Stock-- Common Stock" and
"--Delaware Law and Certain Charter, Bylaw and Other Provisions" in the
Registrant's Registration Statement on Form S-1 (No. 333-31435), as such may
be amended (including any prospectus filed by the Registrant pursuant to Rule
424(b) promulgated under the Securities Act of 1933, as amended).
ITEM 2. EXHIBITS
The securities to be registered are to be registered on The Nasdaq
National Market, on which no other securities of the Registrant are
registered. In accordance with Part II of the instructions as to exhibits on
Form 8-A, the following shall be filed with The Nasdaq National Market:
1. The Registrant's Registration Statement on Form S-1 (No. 333-31435)
2. The Restated Certificate of Incorporation, as amended, of the
Registrant.
3. The Bylaws of the Registrant.
4. Specimen certificate for the Common Stock.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
OSIRIS THERAPEUTICS, INC.
Date: November 24, 1997 By: /s/ James S. Burns
_____________________________
James S. Burns, President and
Chief Executive Officer
3
